Latest Headlines

Latest Headlines

National action plans needed to stop hepatitis B, WHO says

In Asia Pacific viral hepatitis kills one person every 30 seconds. This creates a huge opportunity for vaccines from GlaxoSmithKline, Merck and others to improve public health, yet a lack of national action plans is restricting the impact of these preventative measures.

Indian ethics journal pushes for ban on Crucell vaccine

An Indian medical ethics journal has criticized the World Health Organization for promoting the use of a Crucell vaccine that has been suspended in other countries.

Virus patent sparks debate at WHO meeting

The World Health Assembly met last week with the backdrop of worries about pandemic viruses. In Saudi Arabia the coronavirus death toll is rising, and H7N9 is active in China. The outbreaks--and the global response--put the pandemic influenza preparedness (PIP) framework in the spotlight.

Pfizer's Prevnar 13, GSK's Synflorix pump up vaccination cost

BIO and the International Federation of Pharmaceutical Manufacturers & Associations warn that more funding is needed to maintain current immunization rates while adding new vaccines to programs.

Call for counterfeit drug treaty gets group banned from WHO event

The World Health Organization is banning a group of doctors and academics who are calling for a global treaty on counterfeit drugs from attending an international meeting on the problem, and India may have been the country that nixed them from speaking at the meeting in Argentina.

Meningitis vaccine ruled safe for warm storage

The World Health Organization deemed an inexpensive meningitis vaccine safe out of cold storage for four days, meaning health workers can more easily transport the drug to remote parts of Africa where meningitis A is common.

WHO blames buyers for substandard ingredients

The coordinator for drug quality at the World Health Organization is putting much of the blame for substandard APIs on drugmakers, telling in-PharmaTechnologist that as long as there are companies willing to buy them, there are organizations willing to make them.

AEI suggests booting WHO drugmakers that don't meet the grade

Some companies making drugs for World Health Organization programs in Africa are manufacturing substandard products that can lead to resistance, two new studies find. To get a handle on the problem, the studies' author is recommending that the WHO institute a three strikes and you are out rule for companies that are churning out low-quality products.

Cipla partnership plans $50 million expansion in Uganda

A partnership between Quality Chemical Industries and Cipla is preparing to expand a manufacturing operation in Luzira, Uganda, where it makes HIV drugs.

Shantha gets go-ahead for operational revamp

Sanofi's plan for revamping Shantha Biotech won Indian government approval, clearing the way for it to recapture WHO contracts for its Shan5 vaccine.